1 / 21

Bone Marrow Transplant in Oncology

Bone Marrow Transplant in Oncology. Dr S D Moodley Wits Donald Gordon Medical Centre. Source. Pathology. Treat Leukemia by chemotherapy Regeneration of normal marrow Chemotherapy alone cannot eliminate all malignant cells Stem cell transplants. Tranplant.

Download Presentation

Bone Marrow Transplant in Oncology

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Bone Marrow Transplant in Oncology Dr S D Moodley Wits Donald Gordon Medical Centre

  2. Source

  3. Pathology • Treat Leukemia by chemotherapy • Regeneration of normal marrow • Chemotherapy alone cannot eliminate all malignant cells • Stem cell transplants.

  4. Tranplant • Patient's bone marrow stem cells are replaced with healthy cells • Existing bone marrow and abnormal leukocytes killed • Chemotherapy and radiation • Next bone marrow containing healthy stem cells re-infused

  5. Procedure • Bone Marrow versus Peripheral Stem Cells • Accessibility • Cost • Sample size • Donor/Patient factors • Expertise

  6. Adult Stem Cell Transplant

  7. Procedure • Most blood stem cells reside in the bone marrow and a small number are present in the bloodstream • Multipotent peripheral blood stem cells • Can be obtained from drawn blood • PBSCs are easier to collect than bone marrow stem cells

  8. Harvesting

  9. Umbilical Cord Blood Stem Cell Transplant • Umbilical cords have traditionally been discarded as a by-product of the birth process. • Pluripotent-stem-cell-rich blood found in the umbilical cord rich in marrow stem cells and PBSC’s.

  10. Umbilical Cord Tx • Umbilical cord transplants are less prone to rejection. • Cells have not yet developed the features that can be recognized and attacked by the recipient's immune system. • Umbilical cord blood lacks well-developed immune cells, there is smaller incidence of graft versus host disease.

  11. Cord Blood

  12. THE FUNCTION OF BMT UNIT Handling services & Intensive care for: • Mobilization / stem cell collection & infusion. • Chemotherapy for pre - transplant • Pre & post care for Transplant patients.

  13. Transplantation •   Autologous •   Allogeneic • Syngeneic

  14. Indications • Hematological diseases Benign : Thallassaemia, Aplastic Anaemia Malignant : Leukemia Lymphoma Myeloma • Immune deficiency disorders Pediatric and Adult • Neurological Disease (MS)

  15. Auto Transplant

  16. Recovering from the transplant • Recovery of normal levels cells is called engraftment • Day 8 - 12 • Neutrophil engraftment important (GCSF) may be given to accelerate the process • Platelets are the next to return with red cells last. • Commonly patients require transfusion of red cells and platelets following a transplant. • Discharge upon neutrophil & platelet engraftment

  17. Allotransplant

  18. Graft Verses Host Disease (GVHD) • GVHD sometimes occurs with allogeneic transplantation. • Lymphocytes from the donor graft attack the cells of the host • GVHD can usually be treated with steroids or other immunosuppressive agents. • Acute GVHD occurs before day 100 post-transplant • Chronic GVHD occurs beyond day 100 • Recent advances have reduced the incidence and severity of this post-transplant complication, but GVHD, directly or indirectly, still accounts for approximately 15% of deaths in stem cell transplant patients • Chronic GVHD can develop months or even years post-transplant

  19. GVHD • Skin/Hair Rash, scleroderma, lichenoid skin changes, dyspigmentation,alopecia • Eyes Dryness, abnormal Schirmer's Test, cornealerosions, conjunctivitis  • Mouth Atrophic changes, lichenoid changes, mucositis,ulcers, xerostomia, dental caries • Lungs Bronchiolitis obliterans • GI tract Esophageal involvement, chronic nausea/vomiting, chronic diarrhea, malabsorption, fibrosis, abdomina l pain/cramps • Liver Abnormal LFTs, biopsy abnormalities • Genitourinary Vaginitis, strictures, stenosis, cystitis • Musculoskeletal Arthritis, contractures, myositis, myasthenia, fascities • Hematologic Thrombocytopenia, eosinophilia, autoantibodies

  20. Transplantation • Unit is important • Expertise • Facility Isolation Phoresis Platelet and blood support Motivated patient

  21. Problems • Intensive process that consumes resources • HIV • Donor registry limited • Other health care priorities

More Related